Watchlist Price Alert

Forma Therapeutics Inc. (FMTX)

NASDAQ: FMTX · Real-Time Price · USD

20.01

0.00 (0.00%)

At close: Oct 13, 2022, 8:00 PM

Forma Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019
Period Ending	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019
Cash & Equivalents	75.14M	74.42M	77.42M	87.25M	50.87M	97.83M	282.69M	79.86M	374.95M	110.33M	173.18M
Short-Term Investments	320.77M	346.94M	386.81M	425.43M	484.69M	452.89M	350.37M	286.89M	39.35M	32.11M	n/a
Long-Term Investments	n/a	19.98M	26.05M	19.09M	35.23M	53M	12.53M	17.59M	n/a	n/a	n/a
Other Long-Term Assets	12.84M	12.82M	12.61M	12.94M	15.03M	15.03M	12.47M	12.47M	10.49M	13.52M	620K
Receivables	15.37M	13.75M	13.07M	19.02M	15.24M	17.07M	15.27M	42.34M	37.6M	30.91M	875K
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	15.17M	11.42M	9.11M	3.19M	7.13M	6.07M	6.12M	6.57M	3.21M	3.29M	3.26M
Total Current Assets	426.45M	446.52M	486.4M	534.89M	557.92M	573.87M	654.45M	415.66M	455.12M	176.63M	177.31M
Property-Plant & Equipment	35.89M	35.17M	36M	35.31M	5.18M	8.35M	1.52M	1.67M	1.9M	2.24M	5.1M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	48.72M	67.97M	74.66M	67.34M	55.45M	76.37M	26.52M	31.73M	12.4M	15.76M	5.72M
Total Assets	475.17M	514.5M	561.06M	602.23M	613.37M	650.24M	680.97M	447.4M	467.51M	192.38M	183.03M
Account Payables	3.04M	2.04M	4.14M	4.59M	5.02M	2.93M	4.29M	3.72M	3.75M	1.96M	3.52M
Deferred Revenue	n/a	n/a	n/a	45K	112K	374K	n/a	n/a	n/a	n/a	1.24M
Short-Term Debt	5.33M	5.11M	5.13M	4.54M	1.88M	3.04M	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	25.09M	19.18M	25.82M	23.45M	24.09M	22.21M	27.41M	26.95M	21.07M	19.92M	20.11M
Total Current Liabilities	33.46M	26.34M	35.09M	32.63M	31.1M	28.56M	31.7M	30.67M	24.82M	21.88M	24.87M
Long-Term Debt	27.21M	26.97M	27.62M	26.76M	2.87M	5.21M	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	1.03M	1.13M	4.2M	2.5M	2.62M
Total Long-Term Liabilities	27.21M	26.97M	27.62M	26.76M	2.87M	5.21M	1.03M	1.13M	4.2M	2.5M	2.62M
Total Liabilities	60.68M	53.3M	62.7M	59.39M	33.97M	33.77M	32.73M	31.79M	29.02M	24.38M	27.49M
Total Debt	32.55M	32.08M	32.74M	31.3M	4.76M	8.26M	n/a	n/a	n/a	n/a	n/a
Common Stock	47K	47K	47K	47K	47K	47K	47K	41K	41K	24K	24K
Retained Earnings	-327.11M	-274.53M	-230.37M	-180.25M	-136.96M	-93.37M	-57.41M	-28.82M	-1.21M	26.03M	16.74M
Comprehensive Income	n/a	n/a	n/a	n/a	n/a	n/a	-680.97M	-11.75M	-11.5M	-11.47M	-20.11M
Shareholders Equity	414.49M	461.19M	498.36M	542.83M	579.39M	616.47M	648.24M	415.6M	438.5M	168M	155.55M
Total Investments	320.77M	366.93M	412.85M	444.52M	519.92M	505.89M	362.9M	304.48M	39.35M	32.11M	n/a